@article{3121663,
    title = "Diagnostic accuracy of T2 biomarkers for the prediction of airway eosinophilia in treated smoking asthmatic patients with loss of asthma control",
    author = "Papathanasiou, E. and Bakakos, P. and Hillas, G. and Ntontsi, P. and Blizou, M. and Kostikas, K. and Koulouris, N. and Papiris, S. and Loukides, S.",
    journal = "The Journal of Allergy and Clinical Immunology: In Practice",
    year = "2020",
    volume = "8",
    number = "1",
    pages = "385-387.e2",
    publisher = "American Academy of Allergy, Asthma and Immunology",
    issn = "2213-2198",
    doi = "10.1016/j.jaip.2019.05.052",
    keywords = "biological marker;  immunoglobulin E;  interleukin 13;  nitric oxide;  steroid;  transcription factor RUNX2;  biological marker, airway eosinophilia;  Article;  asthma;  Asthma Control Test;  controlled study;  diagnostic accuracy;  disease control;  eosinophil count;  fractional exhaled nitric oxide;  human;  human cell;  major clinical study;  prediction;  prospective study;  pulmonologist;  respiratory tract disease;  smoking;  sputum analysis;  validation process;  asthma;  eosinophilia;  smoking;  sputum, Asthma;  Biomarkers;  Eosinophilia;  Humans;  Smoking;  Sputum"
}